Join
Live feed
·
PRReleasevia Quantisnow
Apollomics Inc. logo

Apollomics Receives Nasdaq Deficiency Notice Regarding Minimum Market Value Requirement and Updates Rights for Vebreltinib (APL-101) in Asia

ByQuantisnow·Wall Street's wire, on your screen.
APLM· Apollomics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track APLM (Apollomics Inc.) and more on Quantisnow.